Marzia Bonfanti

Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment

Giovanni Mauri, Emanuele Porazzi, Luca Cova et al. · Insights into Imaging · 2014 · 136 citations · Full text

Medicine, Oncology, Surgery +17

Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients

Gualberto Gussoni, Emanuela Foglia, Stefania Frasson et al. · Thrombosis Research · 2012 · 27 citations

Medicine, Internal Medicine, Pharmacoeconomics +17

TECHNOLOGY ASSESSMENT IN HOSPITALS: LESSONS LEARNED FROM AN EMPIRICAL EXPERIMENT

Emanuela Foglia, Emanuele Lettieri, Lucrezia Ferrario et al. · International Journal of Technology Assessment in Health Care · 2017 · 20 citations

Health Professions, Health Administration, Health Services Administration +17

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

Umberto Restelli, Giuliano Rizzardini, Andrea Antinori et al. · Therapeutics and Clinical Risk Management · 2017 · 16 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy

Umberto Restelli, A. Albertí, Adriano Lazzarin et al. · The European Journal of Health Economics · 2016 · 11 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16